Home | Case Studies

  1.   FORMULATION AND IN-VITRO CHARACTERISATION OF SUSTAINED RELEASE MATRIX PELLETS OF NATEGLINIDE
  2.   Evaluation of gum sandarac as a novel release controlling coating polymer for formulation of sustained release pellets
  3.   Development of solidified self-microemulsifying drug delivery systems containing L-tetrahydropalmatine: Design of experiment approach and bioavailability comparison
  4.   Co-processed j-carrageenan-pectin as pelletizing aid for immediate-release pellets
  5.   Formulation and In-vitro Characterization of Multiple Unit Sustained Release Matrix Pellets of Lornoxicam Using Natural Gums
  6.   Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer
  7.   5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer
  8.   Evaluation of gum sandarac as a novel release controlling polymer for sustained release matrix pellets
  9.   Evaluation of hot-melt coating as taste masking tool
  10.   Investigation of PEGylated Derivatives of Rosin as Sustained Release Film Formers
  11.   Formulation and characterization of extruded and spheronized pellets using pectin and crosslinking agents
  12.   Development and evaluation of a hot-melt coating technique for enteric coating
  13.   Development and Characterization of Enteric-Coated Immediate-Release Pellets of Aceclofenac by Extrusion/Spheronization Technique Using κ-Carrageenan as a Pelletizing Agent
  14.   Co-processed κ-carrageenan-pectin as pelletizing aid for immediate-release pellets
  15.   FABRICATION AND CHARACTERIZATION OF Li2TiO3PEBBLES BY AN EXTRUSION AND SPHERODIZATION TECHNIQUE FOR THE TEST BLANKET MODULE IN A FUSION REACTOR
  1.   United States US 20100 197956A1 Patent Application Publication
  2.   Effects of Plastic and Acrylate Polymers on the Release Profile of Ambroxol Hydrochloride Controlled Release Pellets
  3.   Technická univerzita v Liberci Fakulta textilní
  4.   United States Patent (US 8,586,780 B2) Hagemeyer et al.
  5.   United States Patent (US 9,334.226 B2) Bobka et al.
  6.   United States Patent Application Publication Pub. No.: US 2010/0185010 A1 Hagemeyer et al.
  7.   United States Patent Application Publication Pub. No.: US 2015/0126360 A1 US 2015O126360A1 Mest et al.
  8.   Delayed Release Pharmaceutical Pellets having Duloxetine Hydrochloride Containing Core and Acid Resistant Acrylic Polymer Based Outer Layer Coat
  9.   Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer
  10.   Formulation and Evaluation of Novel Enteric-Coated Extended Release Multiparticulate of model NSAID Ketoprofen
  11.   INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES
  12.   Formulation and Evaluation of Release Kinetics of Diltiazem Hydrochloride from Kollicoat SR 30 D Coated Pellets Prepared by Air Suspension Technique
  13.   Formulation and Evaluation of Glipizide pellets by using fluid bed coating method
  14.   TO STUDY AND TO EVALUATE THE REQUIREMENTS REQUIRED TO PROPOSE AN ALTERNATE API FOR AN APPROVED DRUG PRODUCT IN USFDA
  15.   Formulation and Evaluation of Enteric Coated Pellets of Omeprazole
  16.   TO STUDY AND TO EVALUATE THE REQUIREMENTS REQUIRED TO PROPOSE AN ALTERNATE API FOR AN APPROVED DRUG PRODUCT IN USFDA
  17.   Updated Insight of Foam Binder Granulation
  18.   FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF EXTENDED RELEASE MEBEVERINE HCL PELLETS
  19.   FORMULATION AND CHARACTERIZATION OF LANSOPRAZOLE DR PELLETS BY FLUID BED COATING TECHNIQUE
  20.   Preparation andoptimization of various parameters of enteric coated pellets using the Taguchi L9 orthogonal array design and their characterization
  21.   Studies in Formulation Development of Itraconazole Granules Using HPMC E 5 and HPC
  22.   United States Patent Application Publication Pub. No.: US 2010/0185010 A1 Hagemeyer et al.
  23.   United States Patent (US 9,334.226 B2) Bobka et al.
  24.   United States Patent (US 9,873,114 B2) Mestl et al.
  25.   United States Patent Patent No.: US 8,927.452 B2 Hagemeyer et al.
  26.   United States Patent (US 8,586,780 B2) Hagemeyer et al.
  27.   United States Patent Patent No.: US 9,555,397 B2 Hagemeyer et al.
  28.   United States Patent (US 8,722,565 B2) Mest et al.
  29.   FORMULATION AND IN-VITRO EVALUATION OF TEN OF OUR DISOPROXIL FUMARATE IMMEDIATE RELEASE TABLETS
  30.   United States Patent Application Publication Pub. No.: US 2015/0126360 A1 Mest et al.
  31.   United States Patent (US 9,327,272 B2) Szesni et al.
  32.   Formulation and Evaluation of Release Kinetics of Diltiazem Hydrochloride from Kollicoat SR 30 D Coated Pellets Prepared.
  33.   United States Patent (US 8,466,082 B2) Hagemeyer et al.
  34.   Characterization of Soy Polysaccharide and Its In Vitro and In Vivo Evaluation for Application in Colon Drug Delivery
  35.   United States Patent Application Publication Pub. No.: US 2013/0172603 A1 Hagemeyer et al
  36.   United States Patent Application Publication Pub. No.: US 2016/03394.17 A1 SZESN et al.
  37.   Application of Vortex Granulators in Technology of Ammonium Nitrate Obtaining: Main Advantages and Environmental Aspects of Implementation
Content

Contact me